Article Details
Retrieved on: 2021-07-21 16:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies are engineered by pharmaceutical companies to target a single part of the spike protein. The researchers used four of these ...
Article found on: theconversation.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here